# Solving Long Term Side Effects of Chemotherapy Cancer Treatments

Page: https://stenobird.com/podcast/advances-in-care-6039100/solving-long-term-side-effects-of-chemotherapy-cancer-treatments
Text version: https://stenobird.com/podcast/advances-in-care-6039100/solving-long-term-side-effects-of-chemotherapy-cancer-treatments.md
Podcast: [Advances in Care](https://stenobird.com/podcast/advances-in-care-6039100)
Published: 2025-07-24T09:00:00+00:00
Episode link: https://advances-in-care.simplecast.com/episodes/solving-long-term-side-effects-of-chemotherapy-cancer-treatments-DKl4Wjak
Audio file: https://p.podderapp.com/1440337256/cdn.simplecast.com/audio/cc9697ff-ec07-4499-8331-0e85c7cccb15/episodes/0bb8fe4d-03ac-4065-8044-67860605ad63/audio/abb40009-a93b-46e7-8774-58b816871adb/default_tc.mp3?aid=rss_feed&feed=TZu4B0z0
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/advances-in-care-6039100/episodes/solving-long-term-side-effects-of-chemotherapy-cancer-treatments
Duration seconds: 967

## Resource

Dr. Meghna Trivedi, an oncologist at NewYork-Presbyterian and Columbia, discusses new research she is leading to assess risk, and eventually prevent, chemotherapy induced peripheral neuropathy, a common side effect of cancer treatment that can have life-altering consequences for patients.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/advances-in-care-6039100/episodes/solving-long-term-side-effects-of-chemotherapy-cancer-treatments/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/advances-in-care-6039100/solving-long-term-side-effects-of-chemotherapy-cancer-treatments.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.